Overview
SCIENTIFIC SCORE
Moderately Effective
Based on 56 Researches
8.2
USERS' SCORE
Good
Based on 35 Reviews
8.3
Supplement Facts
Serving Size: 1 Veg Capsule
Amount Per Serving
%DV
Blend of Probiotic Bacteria:Lactobacillus acidophilus (La-14),Bifidobacterium lactis (Bl-04),Bifidobacterium longum (Bl-05)
8 Billion CFU
*
Top Medical Research Studies
9.5
Bifidobacterium lactis reduced diarrhea duration
We explored the impact of Bifidobacterium animalis subsp. lactis BLa80 on diarrhea in young children through a well-structured, randomized, double-blinded, placebo-controlled study.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Our findings show that children receiving the probiotic experienced a significantly shorter duration of diarrhea and a higher recovery rate compared to those given a placebo.
Notably, we also observed beneficial changes in gut microbiome composition and gene functions that promote immune response.
This evidence suggests that Bifidobacterium lactis can effectively support recovery from acute diarrhea in children.
Read More
9.5
We explored the effectiveness of a live recombinant Lactococcus lactis vaccine designed to combat enterotoxigenic Escherichia coli, a major cause of diarrhea. The study involved administering the vaccine to mice, who then showed strong immune responses, such as increased antibody production and T cell activation.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
After being challenged with ETEC, these mice exhibited complete protection from the disease. This suggests that the Lactococcus lactis vaccine could be a promising oral vaccine candidate against E. coli-related diarrhea.
Read More
8
We assessed the effectiveness of a new oral vaccine made from lactic acid bacteria (LAB) to prevent diarrhea caused by enterotoxigenic E. coli (ETEC) in piglets.
By immunizing sows and then boosting piglets, our results showed effective protection against ETEC infections. The vaccine helped raise antibodies in colostrum, which protected piglets during crucial growth phases.
This strategy offers hope for better control of ETEC-induced diarrhea, paving the way for future vaccine development in livestock health.
By immunizing sows and then boosting piglets, our results showed effective protection against ETEC infections. The vaccine helped raise antibodies in colostrum, which protected piglets during crucial growth phases.
This strategy offers hope for better control of ETEC-induced diarrhea, paving the way for future vaccine development in livestock health.
Read More
Most Useful Reviews
9
Effective for diarrhea
41 people found this helpful
This product is excellent. As a pharmacist, I recognise its effectiveness for treating diarrhoea. I felt a positive change in my gastrointestinal health within two days. I experienced less indigestion, bloating, and constipation. While there are other effective products, they are often much pricier for less product.
Read More
9
Diarrhea improvement
5 people found this helpful
I had many bad bacteria and suffered from eczema. After starting this supplement, my stools became regular, and my skin looked better. My son also experienced an improvement in his diarrhoea the very next day after he began taking it.
Read More
10
Stopped diarrhea
4 people found this helpful
I was having severe digestion issues and daily diarrhoea. Since I began taking this product, my diarrhoea has completely stopped. I’m incredibly grateful for the relief it provides.
Read More
Medical Researches
SCIENTIFIC SCORE
Moderately Effective
Based on 56 Researches
8.2
- All Researches
9.5
We explored the impact of Lactobacillus acidophilus and L. plantarum on patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D). In a randomized, single-blinded clinical trial of 100 patients, some received standard IBS treatment alone while others added probiotics to their therapy.
After 12 weeks, both groups saw improvements, but those who took probiotics reported significantly better outcomes. Patients using probiotics experienced greater reductions in IBS symptoms, achieving near complete relief, while some on standard treatment still faced moderate symptoms. This suggests probiotics could enhance IBS management.
After 12 weeks, both groups saw improvements, but those who took probiotics reported significantly better outcomes. Patients using probiotics experienced greater reductions in IBS symptoms, achieving near complete relief, while some on standard treatment still faced moderate symptoms. This suggests probiotics could enhance IBS management.
Read More
9.5
We explored the impact of Lactobacillus acidophilus and L. plantarum on patients suffering from diarrhea-predominant irritable bowel syndrome (IBS-D). In a randomized, single-blinded clinical trial of 100 patients, some received standard IBS treatment alone while others added probiotics to their therapy.
After 12 weeks, both groups saw improvements, but those who took probiotics reported significantly better outcomes. Patients using probiotics experienced greater reductions in IBS symptoms, achieving near complete relief, while some on standard treatment still faced moderate symptoms. This suggests probiotics could enhance IBS management.
After 12 weeks, both groups saw improvements, but those who took probiotics reported significantly better outcomes. Patients using probiotics experienced greater reductions in IBS symptoms, achieving near complete relief, while some on standard treatment still faced moderate symptoms. This suggests probiotics could enhance IBS management.
Read More
9.5
Lactobacillus shows promise for diarrhea
We aimed to explore how Lactobacillus acidophilus can help relieve diarrhea symptoms associated with irritable bowel syndrome (IBS) and antibiotic-associated diarrhea (AAD).
In a study with 54 patients, those taking the probiotic Neobiotic Lactobalance® for 21 days saw significant reductions in diarrhea severity and abdominal pain, with scores dropping impressively on the Gastrointestinal Symptom Rating Scale.
Fecal analysis indicated improved intestinal health, highlighting Lactobacillus's potential benefits for those struggling with these conditions.
In a study with 54 patients, those taking the probiotic Neobiotic Lactobalance® for 21 days saw significant reductions in diarrhea severity and abdominal pain, with scores dropping impressively on the Gastrointestinal Symptom Rating Scale.
Fecal analysis indicated improved intestinal health, highlighting Lactobacillus's potential benefits for those struggling with these conditions.
Read More
9.5
Probiotics improve H. pylori treatments
We analyzed various studies on incorporating probiotics into treatments for Helicobacter pylori (H. pylori) infection. Our findings revealed that adding probiotics like Bifidobacterium longum improved the eradication rate significantly.
Specifically, we noted that the probiotic group experienced fewer side effects, including diarrhea, nausea, and abdominal pain. This suggests that probiotics could not only enhance the effectiveness of H. pylori treatment but also make it more comfortable for patients. Overall, these results support the use of probiotics in gastric therapies.
Specifically, we noted that the probiotic group experienced fewer side effects, including diarrhea, nausea, and abdominal pain. This suggests that probiotics could not only enhance the effectiveness of H. pylori treatment but also make it more comfortable for patients. Overall, these results support the use of probiotics in gastric therapies.
Read More
9.5
We conducted a randomized double-blind, placebo-controlled trial with 200 participants to see how well the probiotic CECT 7347 (ES1) and its heat-treated version (HT-ES1) could help those suffering from diarrhea-predominant irritable bowel syndrome (IBS-D). After 12 weeks of treatment, both ES1 and HT-ES1 showed significant improvements in symptom severity, with marked reductions in IBS-SSS scores compared to the placebo.
Secondary benefits included better stool consistency and quality of life, making these treatments promising options for managing IBS-D symptoms. These findings reflect meaningful advancements in probiotic and postbiotic solutions.
Secondary benefits included better stool consistency and quality of life, making these treatments promising options for managing IBS-D symptoms. These findings reflect meaningful advancements in probiotic and postbiotic solutions.
Read More
User Reviews
USERS' SCORE
Good
Based on 35 Reviews
8.3
- All Reviews
- Positive Reviews
- Negative Reviews
9
Effective for diarrhea
41 people found this helpful
This product is excellent. As a pharmacist, I recognise its effectiveness for treating diarrhoea. I felt a positive change in my gastrointestinal health within two days. I experienced less indigestion, bloating, and constipation. While there are other effective products, they are often much pricier for less product.
Read More
9
Diarrhea improvement
5 people found this helpful
I had many bad bacteria and suffered from eczema. After starting this supplement, my stools became regular, and my skin looked better. My son also experienced an improvement in his diarrhoea the very next day after he began taking it.
Read More
10
Stopped diarrhea
4 people found this helpful
I was having severe digestion issues and daily diarrhoea. Since I began taking this product, my diarrhoea has completely stopped. I’m incredibly grateful for the relief it provides.
Read More
9
Diarrhea improvement
2 people found this helpful
I had constipation and recurrent diarrhoea. After starting this product with digestive enzymes, my symptoms improved significantly.
Read More
9
Diarrhea cleared up
2 people found this helpful
A friend recommended probiotics for his diarrhoea, which cleared up quickly. I bought these for a kitten with diarrhoea. He had been dewormed and tested for various issues. After starting these, my own digestion has improved. I was wary about refrigeration, but refrigerating them right after opening, they have definitely helped, so I would recommend trying them.
Read More
Frequently Asked Questions
9
Diarrhea improvement
5 people found this helpful
I had many bad bacteria and suffered from eczema. After starting this supplement, my stools became regular, and my skin looked better. My son also experienced an improvement in his diarrhoea the very next day after he began taking it.
9
Effective for diarrhea
41 people found this helpful
This product is excellent. As a pharmacist, I recognise its effectiveness for treating diarrhoea. I felt a positive change in my gastrointestinal health within two days. I experienced less indigestion, bloating, and constipation. While there are other effective products, they are often much pricier for less product.
9
Cured diarrhea
1 people found this helpful
Immediate improvement! Since that day, I no longer have diarrhoea!
7.5
Reduced diarrhea
5 people found this helpful
Initially, I didn't notice much change, but after a few days, my diarrhoea improved significantly. I have had fewer gas issues, and my bowel movements have become regular. I intend to continue using this product for ongoing gastrointestinal support.
7.5
Improved digestion
1 people found this helpful
I’ve been using it for a year and will buy it again! It improved my digestion without causing diarrhoea and made my intestines function better.
10
No more diarrhoea
It helps digestion in my intestines; I no longer have diarrhoea.
8
Health benefits
12 people found this helpful
My diarrhoea and constipation have ceased, and I’ve noticed skin improvement. My allergies feel slightly better, and I believe health rests heavily on bowel health. This product is beneficial for everyone!
9
Diarrhea improvement
2 people found this helpful
I had constipation and recurrent diarrhoea. After starting this product with digestive enzymes, my symptoms improved significantly.
7.5
Stops diarrhea
2 people found this helpful
This supplement effectively restores intestinal microflora, halting diarrhoea, and is beneficial after taking antibiotics.
7.5
Helpful against diarrhoea
It’s fine to consume, helps with constipation, and seems to alleviate diarrhoea while on antibiotics.
7.5
Reduced diarrhoea
Good, but frequently out of stock. Since I began taking two tablets in the morning and evening, my chronic diarrhoea has improved. The downside is that it is often unavailable.
7.5
Effective against diarrhea
3 people found this helpful
I struggled with gastrointestinal problems and purchased this to improve my gut health. After one day, my diarrhoea improved drastically. I can feel its effectiveness and plan to continue using it.
9
Diarrhoea relief
This product really works. It contains a mix of bifido and acidophilic bacteria. It resolved my family's diarrhoea after antibiotics and helped with constipation as well. I highly recommend it and will purchase more.
9
Lactobacillus acidophilus aids diarrhea recovery
We explored the impact of Lactobacillus acidophilus paired with montmorillonite powder on children suffering from rotavirus enteritis. In a study involving 94 kids, we divided them into two groups. One received standard care, while the other got the probiotic treatment as well. After five days, we found that children receiving the compound had faster relief from diarrhea, vomiting, fever, and dehydration. While there was an improvement in inflammatory responses, the difference in C-reactive protein levels wasn’t significant, and both groups reported a similar rate of side effects.
8
Bifidobacterium lactis shows promise
We investigated whether Bifidobacterium lactis CCT 7858 could help reduce antibiotic-related diarrhea in hospitalized patients. In a rigorous double-blind, randomized, placebo-controlled trial with 104 participants, we found that a significant percentage—about 74.5%—of those taking the probiotic experienced no diarrhea. Additionally, fewer patients reported abdominal distension in the B. lactis group compared to the placebo. While this strain showed promise in alleviating gastrointestinal discomfort, it’s essential to note that some secondary outcomes were modest. Overall, B. lactis appears safe and may offer notable benefits alongside antibiotics.
9
We explored the impact of Bifidobacterium animalis sp. Lactis XLTG11 on acute diarrhea in children through a randomized, double-blinded, placebo-controlled study. Children received either conventional treatment plus the probiotic or conventional treatment alone.
Our findings revealed that the probiotic group experienced shorter diarrhea duration and hospital stays compared to the control group. Additionally, a greater percentage of these children showed improvement, along with significant changes in gut microbiome composition.
These results suggest that XLTG11 can effectively enhance treatment outcomes for diarrhea in children.
Our findings revealed that the probiotic group experienced shorter diarrhea duration and hospital stays compared to the control group. Additionally, a greater percentage of these children showed improvement, along with significant changes in gut microbiome composition.
These results suggest that XLTG11 can effectively enhance treatment outcomes for diarrhea in children.
9
We examined the effectiveness of probiotics in preventing antibiotic-associated diarrhea (AAD) among adult patients. Conducted across several hospitals, our study included 340 participants who received either probiotics or a placebo soon after starting antibiotics.
The results showed that probiotics, specifically Lactobacillus rhamnosus GG and Bifidobacterium longum BB536, significantly reduced both the incidence and duration of AAD. High adherence rates and positive patient feedback added to the supportive findings for probiotics' role in gut health during antibiotic treatment.
The results showed that probiotics, specifically Lactobacillus rhamnosus GG and Bifidobacterium longum BB536, significantly reduced both the incidence and duration of AAD. High adherence rates and positive patient feedback added to the supportive findings for probiotics' role in gut health during antibiotic treatment.
References
- Li S, Lu T, Lin Z, Zhang Y, Zhou X, et al. Supplementation with probiotics co-cultivation improves the reproductive performance in a sow-piglet model by mother-infant microbiota transmission and placental mTOR signaling. World J Microbiol Biotechnol. 2024;41:13. doi:10.1007/s11274-024-04222-5
- Hashem B, Gaston M, Carlisle JD, Van Wick P. COMPARISON OF HAND-REARED PRONGHORN () MILK REPLACER COMPOSITIONS AND GROWTH RATES. J Zoo Wildl Med. 2024;55:1056. doi:10.1638/2023-0112
- Wei Q, Song LY, Rao R, Yang HW, Wen YP, et al. The Impact of Combined Therapy with Lactobacillus acidophilus and Montmorillonite Powder on the Inflammatory Response in Pediatric Rotavirus Enteritis. Int Arch Allergy Immunol. 2024. doi:10.1159/000542593
- Jeong JJ, Jin YJ, Ganesan R, Park HJ, Min BH, et al. Multistrain Probiotics Alleviate Diarrhea by Modulating Microbiome-Derived Metabolites and Serotonin Pathway. Probiotics Antimicrob Proteins. 2024. doi:10.1007/s12602-024-10232-4
- Alharbi BF, Alateek AA. Investigating the influence of probiotics in preventing Traveler's diarrhea: Meta-analysis based systematic review. Travel Med Infect Dis. 2024;59:102703. doi:10.1016/j.tmaid.2024.102703
- Miranda-Yuquilema J, Taboada J, Once V, Coyago M, Briñez W. Effect of Agroindustrial Waste Substrate Fermented with Lactic Acid Bacteria and Yeast on Changes in the Gut Microbiota of Guinea Pigs. Microorganisms. 2024;12. doi:10.3390/microorganisms12010133
- Shanshal SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial. Ceska Slov Farm. 2024;72:233.
- Shanshal SA, Alsaaty MH, Al-Qazaz H, Al-Zidan RN. Two Lactobacilli strains as adjuvant therapy in the management of irritable bowel syndrome: a randomized control trial. Ceska Slov Farm. 2024;73:233.
- Higuchi T, Furuichi M, Maeda N, Tsugawa T, Ito K. Effects of probiotics in children with acute gastroenteritis: A systematic review and meta-analysis focusing on probiotics utilized in Japan. J Infect Chemother. 2024;30:337. doi:10.1016/j.jiac.2023.11.005
- Drozdov VN, Shikh EV, Astapovskii AA, Khalaidzheva KN, Solovieva SA, et al. [Clinical efficacy of a modern probiotic for the correction of intestinal microflora in patients with irritable bowel syndrome with diarrhea and antibiotic-associated diarrhea]. Vopr Pitan. 2023;92:92. doi:10.33029/0042-8833-2023-92-4-92-103
- Lukasik J, Dierikx T, Besseling-van der Vaart I, de Meij T, Szajewska H. Multispecies Probiotic for the Prevention of Antibiotic-Associated Diarrhea in Children: A Randomized Clinical Trial. JAMA Pediatr. 2022;176:860. doi:10.1001/jamapediatrics.2022.1973
- Huang R, Xing HY, Liu HJ, Chen ZF, Tang BB. Efficacy of probiotics in the treatment of acute diarrhea in children: a systematic review and meta-analysis of clinical trials. Transl Pediatr. 2021;10:3248. doi:10.21037/tp-21-511
- Gandhar JS, De UK, Kala A, Malik YS, Yadav S, et al. Efficacy of Microencapsulated Probiotic as Adjunct Therapy on Resolution of Diarrhea, Copper-Zinc Homeostasis, Immunoglobulins, and Inflammatory Markers in Serum of Spontaneous Rotavirus-Infected Diarrhoetic Calves. Probiotics Antimicrob Proteins. 2022;14:1054. doi:10.1007/s12602-021-09862-9
- Kumar M, Kala A, Chaudhary LC, Agarwal N, Kochewad SA. Microencapsulated and Lyophilized Lactobacillus acidophilus Improved Gut Health and Immune Status of Preruminant Calves. Probiotics Antimicrob Proteins. 2022;14:523. doi:10.1007/s12602-021-09821-4
- Chorawala MR, Chauhan S, Patel R, Shah G. Cell Wall Contents of Probiotics (Lactobacillus species) Protect Against Lipopolysaccharide (LPS)-Induced Murine Colitis by Limiting Immuno-inflammation and Oxidative Stress. Probiotics Antimicrob Proteins. 2021;13:1005. doi:10.1007/s12602-020-09738-4
- Gunaratnam S, Diarra C, Paquette PD, Ship N, Millette M, et al. The Acid-Dependent and Independent Effects of Lactobacillus acidophilus CL1285, Lacticaseibacillus casei LBC80R, and Lacticaseibacillus rhamnosus CLR2 on Clostridioides difficile R20291. Probiotics Antimicrob Proteins. 2021;13:949. doi:10.1007/s12602-020-09729-5
- Tanashat M, Abuelazm M, Abouzid M, Al-Ajlouni YA, Ramadan A, et al. Efficacy of probiotics regimens for Helicobacter pylori eradication: A systematic review, pairwise, and network meta-analysis of randomized controlled trials. Clin Nutr ESPEN. 2025;65:424. doi:10.1016/j.clnesp.2024.11.016
- Chen K, Zeng K, Jin S, Ma Y, Cai L, et al. LRa05 in the treatment of acute diarrhea in children: a randomized controlled trial. Front Nutr. 2024;11:1479186. doi:10.3389/fnut.2024.1479186
- Shah J, Adnan SH, Yousaf MS, Din SJU, Haq MU, et al. A Multi-Hospital Comparative Study on the Efficacy of Probiotics Versus Placebo in Preventing Antibiotic-Associated Diarrhea in Adult Patients. Cureus. 2024;16:e70881. doi:10.7759/cureus.70881
- Moreno-Muñoz JA, Ojeda JD, López JJ. A Probiotic Bacterium with Activity against the Most Frequent Bacteria and Viruses Causing Pediatric Diarrhea: subsp. CECT 7210 ( IM1). Microorganisms. 2024;12. doi:10.3390/microorganisms12061183
- Srivastava S, Basak U, Naghibi M, Vijayakumar V, Parihar R, et al. A randomized double-blind, placebo-controlled trial to evaluate the safety and efficacy of live CECT 7347 (ES1) and heat-treated CECT 7347 (HT-ES1) in participants with diarrhea-predominant irritable bowel syndrome. Gut Microbes. 2024;16:2338322. doi:10.1080/19490976.2024.2338322
- Lenoir M, Wienke J, Fardao-Beyler F, Roese N. An 8-Week Course of Bifidobacterium longum 35624 Is Associated with a Reduction in the Symptoms of Irritable Bowel Syndrome. Probiotics Antimicrob Proteins. 2025;17:315. doi:10.1007/s12602-023-10151-w
- Chen K, Jin S, Ma Y, Cai L, Xu P, et al. Adjunctive efficacy of Lactis XLTG11 for Acute diarrhea in children: A randomized, blinded, placebo-controlled study. Nutrition. 2023;111:112052. doi:10.1016/j.nut.2023.112052
- Li W, Zhang S, Wang Y, Bian H, Yu S, et al. Complex probiotics alleviate ampicillin-induced antibiotic-associated diarrhea in mice. Front Microbiol. 2023;14:1156058. doi:10.3389/fmicb.2023.1156058
- Mizutani Y, Kawamoto S, Takahashi M, Doi H, Wakida K, et al. Efficacy and Safety of Synbiotics in Patients Undergoing Autologous Hematopoietic Stem Cell Transplantation: A Randomized, Double-blinded, Placebo-controlled Pilot Study. Intern Med. 2023;62:2949. doi:10.2169/internalmedicine.1314-22
- Yalcin G, Demirbas F, Bacalan F, Toy EB. Evaluation of treatment in acute gastroenteritis: A comparative study. J Pak Med Assoc. 2022;72:2019. doi:10.47391/JPMA.4438
- Li W, Kai L, Jiang Z, He H, Yang M, et al. , and Reversed ETEC-Inducing Intestinal Inflammation in Mice. Microorganisms. 2022;10. doi:10.3390/microorganisms10122350
- Yakovenko EP, Strokova TV, Ivanov AN, Iakovenko AV, Gioeva IZ, et al. [The effectiveness of a probiotic containing Bifidobacterium longum BB-46 and Enterococcus faecium ENCfa-68 in the treatment of post-infectious irritable bowel syndrome. Prospective randomized comparative study]. Ter Arkh. 2022;94:180. doi:10.26442/00403660.2022.02.201368
- Shin SY, Park S, Moon JM, Kim K, Kim JW, et al. Compositional Changes in the Gut Microbiota of Responders and Non-responders to Probiotic Treatment Among Patients With Diarrhea-predominant Irritable Bowel Syndrome: A Post Hoc Analysis of a Randomized Clinical Trial. J Neurogastroenterol Motil. 2022;28:642. doi:10.5056/jnm21202
- Álvarez-Mercado AI, Plaza-Díaz J, de Almagro MC, Gil Á, Moreno-Muñoz JA, et al. subsp. CECT 7210 Reduces Inflammatory Cytokine Secretion in Caco-2 Cells Cultured in the Presence of CECT 515. Int J Mol Sci. 2022;23. doi:10.3390/ijms231810813
- Moreno-Muñoz JA, Martín-Palomas M, Jiménez López J. [Bifidobacterium longum subsp. infantis CECT 7210 (B. infantis IM-1®) shows activity against intestinal pathogens]. Nutr Hosp. 2022;39:65. doi:10.20960/nh.04315
- Uttarwar RG, Mekonnen SA, Van Beeck W, Wang A, Finnegan P, et al. Effects of Bifidobacterium animalis subsp. lactis BB-12 and yogurt on mice during oral antibiotic administration. Microbiol Res. 2024;286:127794. doi:10.1016/j.micres.2024.127794
- Chen K, Jin S, Ma Y, Cai L, Xu P, et al. Adjudicative efficacy of Bifidobacterium animalis subsp. lactis BLa80 in treating acute diarrhea in children: a randomized, double-blinded, placebo-controlled study. Eur J Clin Nutr. 2024;78:501. doi:10.1038/s41430-024-01428-6
- Pang J, Liu Y, Kang L, Ye H, Zang J, et al. Bifidobacterium animalis Promotes the Growth of Weaning Piglets by Improving Intestinal Development, Enhancing Antioxidant Capacity, and Modulating Gut Microbiota. Appl Environ Microbiol. 2022;88:e0129622. doi:10.1128/aem.01296-22
- Şahin K, Şahintürk Y, Köker G, Özçelik Köker G, Bostan F, et al. Metformin with Versus without Concomitant Probiotic Therapy in Newly Diagnosed Patients with Type 2 Diabetes or Prediabetes: A Comparative Analysis in Relation to Glycemic Control, Gastrointestinal Side Effects, and Treatment Compliance. Turk J Gastroenterol. 2022;33:925. doi:10.5152/tjg.2022.211063
- Xu B, Liang S, Zhao J, Li X, Guo J, et al. subsp. XLTG11 improves antibiotic-related diarrhea by alleviating inflammation, enhancing intestinal barrier function and regulating intestinal flora. Food Funct. 2022;13:6404. doi:10.1039/d1fo04305f
- Liu B, Wang C, Huasai S, Han A, Zhang J, et al. Compound Probiotics Improve the Diarrhea Rate and Intestinal Microbiota of Newborn Calves. Animals (Basel). 2022;12. doi:10.3390/ani12030322
- Michels M, Córneo E, Cucker L, Simon CS, de Jesus GFA, et al. Bifidobacterium lactis CCT 7858 Improves Gastrointestinal Symptoms by Antibiotics Treatment: a Double-Blind, Randomized, Placebo-Controlled Trial. Probiotics Antimicrob Proteins. 2023;15:738. doi:10.1007/s12602-021-09900-6
- Cheng J, Laitila A, Ouwehand AC. subsp. HN019 Effects on Gut Health: A Review. Front Nutr. 2021;8:790561. doi:10.3389/fnut.2021.790561
- Li Z, Zhu G, Li C, Lai H, Liu X, et al. Which Probiotic Is the Most Effective for Treating Acute Diarrhea in Children? A Bayesian Network Meta-Analysis of Randomized Controlled Trials. Nutrients. 2021;13. doi:10.3390/nu13124319
- Guo Y, Li Z, Deng M, Li Y, Liu G, et al. Effects of a multi-strain probiotic on growth, health, and fecal bacterial flora of neonatal dairy calves. Anim Biosci. 2022;35:204. doi:10.5713/ab.21.0084
- Merenstein D, Fraser CM, Roberts RF, Liu T, Grant-Beurmann S, et al. subsp. BB-12 Protects against Antibiotic-Induced Functional and Compositional Changes in Human Fecal Microbiome. Nutrients. 2021;13. doi:10.3390/nu13082814
- Kluijfhout S, Trieu TV, Vandenplas Y. Efficacy of the Probiotic Probiotical Confirmed in Acute Gastroenteritis. Pediatr Gastroenterol Hepatol Nutr. 2020;23:464. doi:10.5223/pghn.2020.23.5.464
- Anvarifard P, Anbari M, Ghalichi F, Ghoreishi Z, Zarezadeh M. The effectiveness of probiotics as an adjunct therapy in patients under mechanical ventilation: an umbrella systematic review and meta-analysis. Food Funct. 2024;15:5737. doi:10.1039/d3fo04653b
- Cai X, Yi P, Chen X, Wu J, Lan G, et al. Intake of compound probiotics accelerates the construction of immune function and gut microbiome in Holstein calves. Microbiol Spectr. 2024;12:e0190923. doi:10.1128/spectrum.01909-23
- Yu J, Fu J, Liu H, Kang C, Wang Z, et al. Application of Recombinant Lactic Acid Bacteria (LAB) Live Vector Oral Vaccine in the Prevention of F4+ Enterotoxigenic . Vaccines (Basel). 2024;12. doi:10.3390/vaccines12030304
- Jaramillo-Jaramillo AS, Blanvillain-Rivera V, Coulson TJD, Farzan V, Friendship R, et al. Effect of a culture supernatant on diarrhea and performance parameters of piglets in the post-weaning period and on expression of the gene . Can Vet J. 2024;65:259.
- Thu NN, Mai TT, Trang TTT, Tuan NA, Quyen TC, et al. Impact of Infectious Disease after Strain Plasma Intake in Vietnamese Schoolchildren: A Randomized, Placebo-Controlled, Double-Blind Study. Nutrients. 2022;14. doi:10.3390/nu14030552
- Ahmadi Rouzbahani H, Mousavi Gargari SL, Nazarian S, Abdollahi S. Protective Immunity Against Enterotoxigenic Escherichia coli by Oral Vaccination of Engineered Lactococcus lactis. Curr Microbiol. 2021;78:3464. doi:10.1007/s00284-021-02601-x
- Zhang K, Mirza WA, Ni P, Yu M, Wang C, et al. Recombination Lactococcus lactis expressing Helicobacter pylori neutrophil-activating protein A attenuates food allergy symptoms in mice. FEMS Microbiol Lett. 2021;368. doi:10.1093/femsle/fnab034
- Song J, Zhao L, Song M. A Lactococcus lactis-vectored oral vaccine induces protective immunity of mice against enterotoxigenic Escherichia coli lethal challenge. Immunol Lett. 2020;225:57. doi:10.1016/j.imlet.2020.06.007
- Wang J, Tian M, Li W, Hao F. Preventative delivery of IL-35 by Lactococcus lactis ameliorates DSS-induced colitis in mice. Appl Microbiol Biotechnol. 2019;103:7931. doi:10.1007/s00253-019-10094-9
- Lay CL, Dridi L, Bergeron MG, Ouellette M, Fliss IL. Nisin is an effective inhibitor of Clostridium difficile vegetative cells and spore germination. J Med Microbiol. 2016;65:169. doi:10.1099/jmm.0.000202
- Guo S, Yan W, McDonough SP, Lin N, Wu KJ, et al. The recombinant Lactococcus lactis oral vaccine induces protection against C. difficile spore challenge in a mouse model. Vaccine. 2015;33:1586. doi:10.1016/j.vaccine.2015.02.006
- Yang XQ, Zhao YG, Chen XQ, Jiang B, Sun DY. The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model. BMC Gastroenterol. 2013;13:117. doi:10.1186/1471-230X-13-117
- Zamri HF, Shamsudin MN, Rahim RA, Neela V. Oral vaccination with Lactococcus lactis expressing the Vibrio cholerae Wzm protein to enhance mucosal and systemic immunity. Vaccine. 2012;30:3231. doi:10.1016/j.vaccine.2012.02.012
